Network-based selectivity of antiparasitic inhibitors

Molecular Biology Reports

Volumn 29, Issue 1-2, 2002, Pages 1-5

  Bakker, Barbara M ^a   Assmus, Heike E ^b   Bruggeman, Frank ^a   Haanstra, Jurgen R ^a   Klipp, Edda ^b   Westerhoff, Hans ^a  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

^b HUMBOLDT UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPARASITIC AGENT; ENZYME INHIBITOR;

ANIMAL; ARTICLE; BINDING COMPETITION; BINDING SITE; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; HUMAN; METABOLISM; PARASITE; PROTEIN BINDING; TRYPANOSOMA BRUCEI;

ANIMALS; ANTIPARASITIC AGENTS; BINDING SITES; BINDING, COMPETITIVE; ENZYME INHIBITORS; HUMANS; PARASITES; PROTEIN BINDING; TRYPANOSOMA BRUCEI BRUCEI;

EID: 0036042278     PISSN: 03014851     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020397513646     Document Type: Article

References (5)

1. Structure-based drug design: Progress, results and challenges
2. Prospects for antiparasitic drugs. The case of Trypanosoma brucei, the causative agent of African sleeping sickness